Global CD115 Antibody Market Growth 2026-2032
The global CD115 Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
CD115 (CSF-1R) is expressed on monocytes/macrophages, peritoneal exudate cells, plasmacytoid cells, dendritic cells, and osteoclasts. Background. CD115 antibody, clone AFS98, recognizes CD115, also known as mouse colony-stimulating factor 1 receptor (CSF-1R and macrophage colony-stimulating factor receptor (M-CSFR).
United States market for CD115 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for CD115 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for CD115 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key CD115 Antibody players cover Thermo Fisher Scientific, BosterBio, Bioss, BD Biosciences, RayBiotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “CD115 Antibody Industry Forecast” looks at past sales and reviews total world CD115 Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected CD115 Antibody sales for 2026 through 2032. With CD115 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CD115 Antibody industry.
This Insight Report provides a comprehensive analysis of the global CD115 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CD115 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CD115 Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CD115 Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CD115 Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of CD115 Antibody market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global CD115 Antibody market?
What factors are driving CD115 Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do CD115 Antibody market opportunities vary by end market size?
How does CD115 Antibody break out by Type, by Application?
CD115 (CSF-1R) is expressed on monocytes/macrophages, peritoneal exudate cells, plasmacytoid cells, dendritic cells, and osteoclasts. Background. CD115 antibody, clone AFS98, recognizes CD115, also known as mouse colony-stimulating factor 1 receptor (CSF-1R and macrophage colony-stimulating factor receptor (M-CSFR).
United States market for CD115 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for CD115 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for CD115 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key CD115 Antibody players cover Thermo Fisher Scientific, BosterBio, Bioss, BD Biosciences, RayBiotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “CD115 Antibody Industry Forecast” looks at past sales and reviews total world CD115 Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected CD115 Antibody sales for 2026 through 2032. With CD115 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CD115 Antibody industry.
This Insight Report provides a comprehensive analysis of the global CD115 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CD115 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CD115 Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CD115 Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CD115 Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of CD115 Antibody market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monoclonal
- Polyclonal
- Immunochemistry (IHC)
- Immunofluorescence (IF)
- Immunoprecipitation (IP)
- Western Blot (WB)
- ELISA
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific
- BosterBio
- Bioss
- BD Biosciences
- RayBiotech
- BioLegend
- LifeSpan BioSciences
- Bio-Rad
- Antigenix America
- Leinco Technologies
- Novus Biologicals
- Tonbo Biosciences
- ichorbio
- R&D Systems
- AffinityImmuno
- Proteintech Group
- GeneTex
- Biobyt
- Jingjie PTM BioLab
What is the 10-year outlook for the global CD115 Antibody market?
What factors are driving CD115 Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do CD115 Antibody market opportunities vary by end market size?
How does CD115 Antibody break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CD115 Antibody Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for CD115 Antibody by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for CD115 Antibody by Country/Region, 2021, 2025 & 2032
2.2 CD115 Antibody Segment by Type
2.2.1 Monoclonal
2.2.2 Polyclonal
2.2.3 CD115 Antibody Sales by Type
2.2.3.1 Global CD115 Antibody Sales Market Share by Type (2021-2026)
2.2.3.2 Global CD115 Antibody Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global CD115 Antibody Sale Price by Type (2021-2026)
2.3 CD115 Antibody Segment by Application
2.3.1 Immunochemistry (IHC)
2.3.2 Immunofluorescence (IF)
2.3.3 Immunoprecipitation (IP)
2.3.4 Western Blot (WB)
2.3.5 ELISA
2.3.6 Others
2.3.7 CD115 Antibody Sales by Application
2.3.7.1 Global CD115 Antibody Sale Market Share by Application (2021-2026)
2.3.7.2 Global CD115 Antibody Revenue and Market Share by Application (2021-2026)
2.3.7.3 Global CD115 Antibody Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global CD115 Antibody Breakdown Data by Company
3.1.1 Global CD115 Antibody Annual Sales by Company (2021-2026)
3.1.2 Global CD115 Antibody Sales Market Share by Company (2021-2026)
3.2 Global CD115 Antibody Annual Revenue by Company (2021-2026)
3.2.1 Global CD115 Antibody Revenue by Company (2021-2026)
3.2.2 Global CD115 Antibody Revenue Market Share by Company (2021-2026)
3.3 Global CD115 Antibody Sale Price by Company
3.4 Key Manufacturers CD115 Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CD115 Antibody Product Location Distribution
3.4.2 Players CD115 Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CD115 ANTIBODY BY GEOGRAPHIC REGION
4.1 World Historic CD115 Antibody Market Size by Geographic Region (2021-2026)
4.1.1 Global CD115 Antibody Annual Sales by Geographic Region (2021-2026)
4.1.2 Global CD115 Antibody Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic CD115 Antibody Market Size by Country/Region (2021-2026)
4.2.1 Global CD115 Antibody Annual Sales by Country/Region (2021-2026)
4.2.2 Global CD115 Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas CD115 Antibody Sales Growth
4.4 APAC CD115 Antibody Sales Growth
4.5 Europe CD115 Antibody Sales Growth
4.6 Middle East & Africa CD115 Antibody Sales Growth
5 AMERICAS
5.1 Americas CD115 Antibody Sales by Country
5.1.1 Americas CD115 Antibody Sales by Country (2021-2026)
5.1.2 Americas CD115 Antibody Revenue by Country (2021-2026)
5.2 Americas CD115 Antibody Sales by Type (2021-2026)
5.3 Americas CD115 Antibody Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CD115 Antibody Sales by Region
6.1.1 APAC CD115 Antibody Sales by Region (2021-2026)
6.1.2 APAC CD115 Antibody Revenue by Region (2021-2026)
6.2 APAC CD115 Antibody Sales by Type (2021-2026)
6.3 APAC CD115 Antibody Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe CD115 Antibody by Country
7.1.1 Europe CD115 Antibody Sales by Country (2021-2026)
7.1.2 Europe CD115 Antibody Revenue by Country (2021-2026)
7.2 Europe CD115 Antibody Sales by Type (2021-2026)
7.3 Europe CD115 Antibody Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CD115 Antibody by Country
8.1.1 Middle East & Africa CD115 Antibody Sales by Country (2021-2026)
8.1.2 Middle East & Africa CD115 Antibody Revenue by Country (2021-2026)
8.2 Middle East & Africa CD115 Antibody Sales by Type (2021-2026)
8.3 Middle East & Africa CD115 Antibody Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CD115 Antibody
10.3 Manufacturing Process Analysis of CD115 Antibody
10.4 Industry Chain Structure of CD115 Antibody
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CD115 Antibody Distributors
11.3 CD115 Antibody Customer
12 WORLD FORECAST REVIEW FOR CD115 ANTIBODY BY GEOGRAPHIC REGION
12.1 Global CD115 Antibody Market Size Forecast by Region
12.1.1 Global CD115 Antibody Forecast by Region (2027-2032)
12.1.2 Global CD115 Antibody Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global CD115 Antibody Forecast by Type (2027-2032)
12.7 Global CD115 Antibody Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Information
13.1.2 Thermo Fisher Scientific CD115 Antibody Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Thermo Fisher Scientific Main Business Overview
13.1.5 Thermo Fisher Scientific Latest Developments
13.2 BosterBio
13.2.1 BosterBio Company Information
13.2.2 BosterBio CD115 Antibody Product Portfolios and Specifications
13.2.3 BosterBio CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BosterBio Main Business Overview
13.2.5 BosterBio Latest Developments
13.3 Bioss
13.3.1 Bioss Company Information
13.3.2 Bioss CD115 Antibody Product Portfolios and Specifications
13.3.3 Bioss CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bioss Main Business Overview
13.3.5 Bioss Latest Developments
13.4 BD Biosciences
13.4.1 BD Biosciences Company Information
13.4.2 BD Biosciences CD115 Antibody Product Portfolios and Specifications
13.4.3 BD Biosciences CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BD Biosciences Main Business Overview
13.4.5 BD Biosciences Latest Developments
13.5 RayBiotech
13.5.1 RayBiotech Company Information
13.5.2 RayBiotech CD115 Antibody Product Portfolios and Specifications
13.5.3 RayBiotech CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 RayBiotech Main Business Overview
13.5.5 RayBiotech Latest Developments
13.6 BioLegend
13.6.1 BioLegend Company Information
13.6.2 BioLegend CD115 Antibody Product Portfolios and Specifications
13.6.3 BioLegend CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 BioLegend Main Business Overview
13.6.5 BioLegend Latest Developments
13.7 LifeSpan BioSciences
13.7.1 LifeSpan BioSciences Company Information
13.7.2 LifeSpan BioSciences CD115 Antibody Product Portfolios and Specifications
13.7.3 LifeSpan BioSciences CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 LifeSpan BioSciences Main Business Overview
13.7.5 LifeSpan BioSciences Latest Developments
13.8 Bio-Rad
13.8.1 Bio-Rad Company Information
13.8.2 Bio-Rad CD115 Antibody Product Portfolios and Specifications
13.8.3 Bio-Rad CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bio-Rad Main Business Overview
13.8.5 Bio-Rad Latest Developments
13.9 Antigenix America
13.9.1 Antigenix America Company Information
13.9.2 Antigenix America CD115 Antibody Product Portfolios and Specifications
13.9.3 Antigenix America CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Antigenix America Main Business Overview
13.9.5 Antigenix America Latest Developments
13.10 Leinco Technologies
13.10.1 Leinco Technologies Company Information
13.10.2 Leinco Technologies CD115 Antibody Product Portfolios and Specifications
13.10.3 Leinco Technologies CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Leinco Technologies Main Business Overview
13.10.5 Leinco Technologies Latest Developments
13.11 Novus Biologicals
13.11.1 Novus Biologicals Company Information
13.11.2 Novus Biologicals CD115 Antibody Product Portfolios and Specifications
13.11.3 Novus Biologicals CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Novus Biologicals Main Business Overview
13.11.5 Novus Biologicals Latest Developments
13.12 Tonbo Biosciences
13.12.1 Tonbo Biosciences Company Information
13.12.2 Tonbo Biosciences CD115 Antibody Product Portfolios and Specifications
13.12.3 Tonbo Biosciences CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Tonbo Biosciences Main Business Overview
13.12.5 Tonbo Biosciences Latest Developments
13.13 ichorbio
13.13.1 ichorbio Company Information
13.13.2 ichorbio CD115 Antibody Product Portfolios and Specifications
13.13.3 ichorbio CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 ichorbio Main Business Overview
13.13.5 ichorbio Latest Developments
13.14 R&D Systems
13.14.1 R&D Systems Company Information
13.14.2 R&D Systems CD115 Antibody Product Portfolios and Specifications
13.14.3 R&D Systems CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 R&D Systems Main Business Overview
13.14.5 R&D Systems Latest Developments
13.15 AffinityImmuno
13.15.1 AffinityImmuno Company Information
13.15.2 AffinityImmuno CD115 Antibody Product Portfolios and Specifications
13.15.3 AffinityImmuno CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 AffinityImmuno Main Business Overview
13.15.5 AffinityImmuno Latest Developments
13.16 Proteintech Group
13.16.1 Proteintech Group Company Information
13.16.2 Proteintech Group CD115 Antibody Product Portfolios and Specifications
13.16.3 Proteintech Group CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Proteintech Group Main Business Overview
13.16.5 Proteintech Group Latest Developments
13.17 GeneTex
13.17.1 GeneTex Company Information
13.17.2 GeneTex CD115 Antibody Product Portfolios and Specifications
13.17.3 GeneTex CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 GeneTex Main Business Overview
13.17.5 GeneTex Latest Developments
13.18 Biobyt
13.18.1 Biobyt Company Information
13.18.2 Biobyt CD115 Antibody Product Portfolios and Specifications
13.18.3 Biobyt CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Biobyt Main Business Overview
13.18.5 Biobyt Latest Developments
13.19 Jingjie PTM BioLab
13.19.1 Jingjie PTM BioLab Company Information
13.19.2 Jingjie PTM BioLab CD115 Antibody Product Portfolios and Specifications
13.19.3 Jingjie PTM BioLab CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Jingjie PTM BioLab Main Business Overview
13.19.5 Jingjie PTM BioLab Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CD115 Antibody Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for CD115 Antibody by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for CD115 Antibody by Country/Region, 2021, 2025 & 2032
2.2 CD115 Antibody Segment by Type
2.2.1 Monoclonal
2.2.2 Polyclonal
2.2.3 CD115 Antibody Sales by Type
2.2.3.1 Global CD115 Antibody Sales Market Share by Type (2021-2026)
2.2.3.2 Global CD115 Antibody Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global CD115 Antibody Sale Price by Type (2021-2026)
2.3 CD115 Antibody Segment by Application
2.3.1 Immunochemistry (IHC)
2.3.2 Immunofluorescence (IF)
2.3.3 Immunoprecipitation (IP)
2.3.4 Western Blot (WB)
2.3.5 ELISA
2.3.6 Others
2.3.7 CD115 Antibody Sales by Application
2.3.7.1 Global CD115 Antibody Sale Market Share by Application (2021-2026)
2.3.7.2 Global CD115 Antibody Revenue and Market Share by Application (2021-2026)
2.3.7.3 Global CD115 Antibody Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global CD115 Antibody Breakdown Data by Company
3.1.1 Global CD115 Antibody Annual Sales by Company (2021-2026)
3.1.2 Global CD115 Antibody Sales Market Share by Company (2021-2026)
3.2 Global CD115 Antibody Annual Revenue by Company (2021-2026)
3.2.1 Global CD115 Antibody Revenue by Company (2021-2026)
3.2.2 Global CD115 Antibody Revenue Market Share by Company (2021-2026)
3.3 Global CD115 Antibody Sale Price by Company
3.4 Key Manufacturers CD115 Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CD115 Antibody Product Location Distribution
3.4.2 Players CD115 Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CD115 ANTIBODY BY GEOGRAPHIC REGION
4.1 World Historic CD115 Antibody Market Size by Geographic Region (2021-2026)
4.1.1 Global CD115 Antibody Annual Sales by Geographic Region (2021-2026)
4.1.2 Global CD115 Antibody Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic CD115 Antibody Market Size by Country/Region (2021-2026)
4.2.1 Global CD115 Antibody Annual Sales by Country/Region (2021-2026)
4.2.2 Global CD115 Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas CD115 Antibody Sales Growth
4.4 APAC CD115 Antibody Sales Growth
4.5 Europe CD115 Antibody Sales Growth
4.6 Middle East & Africa CD115 Antibody Sales Growth
5 AMERICAS
5.1 Americas CD115 Antibody Sales by Country
5.1.1 Americas CD115 Antibody Sales by Country (2021-2026)
5.1.2 Americas CD115 Antibody Revenue by Country (2021-2026)
5.2 Americas CD115 Antibody Sales by Type (2021-2026)
5.3 Americas CD115 Antibody Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CD115 Antibody Sales by Region
6.1.1 APAC CD115 Antibody Sales by Region (2021-2026)
6.1.2 APAC CD115 Antibody Revenue by Region (2021-2026)
6.2 APAC CD115 Antibody Sales by Type (2021-2026)
6.3 APAC CD115 Antibody Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe CD115 Antibody by Country
7.1.1 Europe CD115 Antibody Sales by Country (2021-2026)
7.1.2 Europe CD115 Antibody Revenue by Country (2021-2026)
7.2 Europe CD115 Antibody Sales by Type (2021-2026)
7.3 Europe CD115 Antibody Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CD115 Antibody by Country
8.1.1 Middle East & Africa CD115 Antibody Sales by Country (2021-2026)
8.1.2 Middle East & Africa CD115 Antibody Revenue by Country (2021-2026)
8.2 Middle East & Africa CD115 Antibody Sales by Type (2021-2026)
8.3 Middle East & Africa CD115 Antibody Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CD115 Antibody
10.3 Manufacturing Process Analysis of CD115 Antibody
10.4 Industry Chain Structure of CD115 Antibody
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CD115 Antibody Distributors
11.3 CD115 Antibody Customer
12 WORLD FORECAST REVIEW FOR CD115 ANTIBODY BY GEOGRAPHIC REGION
12.1 Global CD115 Antibody Market Size Forecast by Region
12.1.1 Global CD115 Antibody Forecast by Region (2027-2032)
12.1.2 Global CD115 Antibody Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global CD115 Antibody Forecast by Type (2027-2032)
12.7 Global CD115 Antibody Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Information
13.1.2 Thermo Fisher Scientific CD115 Antibody Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Thermo Fisher Scientific Main Business Overview
13.1.5 Thermo Fisher Scientific Latest Developments
13.2 BosterBio
13.2.1 BosterBio Company Information
13.2.2 BosterBio CD115 Antibody Product Portfolios and Specifications
13.2.3 BosterBio CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BosterBio Main Business Overview
13.2.5 BosterBio Latest Developments
13.3 Bioss
13.3.1 Bioss Company Information
13.3.2 Bioss CD115 Antibody Product Portfolios and Specifications
13.3.3 Bioss CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bioss Main Business Overview
13.3.5 Bioss Latest Developments
13.4 BD Biosciences
13.4.1 BD Biosciences Company Information
13.4.2 BD Biosciences CD115 Antibody Product Portfolios and Specifications
13.4.3 BD Biosciences CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BD Biosciences Main Business Overview
13.4.5 BD Biosciences Latest Developments
13.5 RayBiotech
13.5.1 RayBiotech Company Information
13.5.2 RayBiotech CD115 Antibody Product Portfolios and Specifications
13.5.3 RayBiotech CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 RayBiotech Main Business Overview
13.5.5 RayBiotech Latest Developments
13.6 BioLegend
13.6.1 BioLegend Company Information
13.6.2 BioLegend CD115 Antibody Product Portfolios and Specifications
13.6.3 BioLegend CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 BioLegend Main Business Overview
13.6.5 BioLegend Latest Developments
13.7 LifeSpan BioSciences
13.7.1 LifeSpan BioSciences Company Information
13.7.2 LifeSpan BioSciences CD115 Antibody Product Portfolios and Specifications
13.7.3 LifeSpan BioSciences CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 LifeSpan BioSciences Main Business Overview
13.7.5 LifeSpan BioSciences Latest Developments
13.8 Bio-Rad
13.8.1 Bio-Rad Company Information
13.8.2 Bio-Rad CD115 Antibody Product Portfolios and Specifications
13.8.3 Bio-Rad CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bio-Rad Main Business Overview
13.8.5 Bio-Rad Latest Developments
13.9 Antigenix America
13.9.1 Antigenix America Company Information
13.9.2 Antigenix America CD115 Antibody Product Portfolios and Specifications
13.9.3 Antigenix America CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Antigenix America Main Business Overview
13.9.5 Antigenix America Latest Developments
13.10 Leinco Technologies
13.10.1 Leinco Technologies Company Information
13.10.2 Leinco Technologies CD115 Antibody Product Portfolios and Specifications
13.10.3 Leinco Technologies CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Leinco Technologies Main Business Overview
13.10.5 Leinco Technologies Latest Developments
13.11 Novus Biologicals
13.11.1 Novus Biologicals Company Information
13.11.2 Novus Biologicals CD115 Antibody Product Portfolios and Specifications
13.11.3 Novus Biologicals CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Novus Biologicals Main Business Overview
13.11.5 Novus Biologicals Latest Developments
13.12 Tonbo Biosciences
13.12.1 Tonbo Biosciences Company Information
13.12.2 Tonbo Biosciences CD115 Antibody Product Portfolios and Specifications
13.12.3 Tonbo Biosciences CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Tonbo Biosciences Main Business Overview
13.12.5 Tonbo Biosciences Latest Developments
13.13 ichorbio
13.13.1 ichorbio Company Information
13.13.2 ichorbio CD115 Antibody Product Portfolios and Specifications
13.13.3 ichorbio CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 ichorbio Main Business Overview
13.13.5 ichorbio Latest Developments
13.14 R&D Systems
13.14.1 R&D Systems Company Information
13.14.2 R&D Systems CD115 Antibody Product Portfolios and Specifications
13.14.3 R&D Systems CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 R&D Systems Main Business Overview
13.14.5 R&D Systems Latest Developments
13.15 AffinityImmuno
13.15.1 AffinityImmuno Company Information
13.15.2 AffinityImmuno CD115 Antibody Product Portfolios and Specifications
13.15.3 AffinityImmuno CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 AffinityImmuno Main Business Overview
13.15.5 AffinityImmuno Latest Developments
13.16 Proteintech Group
13.16.1 Proteintech Group Company Information
13.16.2 Proteintech Group CD115 Antibody Product Portfolios and Specifications
13.16.3 Proteintech Group CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Proteintech Group Main Business Overview
13.16.5 Proteintech Group Latest Developments
13.17 GeneTex
13.17.1 GeneTex Company Information
13.17.2 GeneTex CD115 Antibody Product Portfolios and Specifications
13.17.3 GeneTex CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 GeneTex Main Business Overview
13.17.5 GeneTex Latest Developments
13.18 Biobyt
13.18.1 Biobyt Company Information
13.18.2 Biobyt CD115 Antibody Product Portfolios and Specifications
13.18.3 Biobyt CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Biobyt Main Business Overview
13.18.5 Biobyt Latest Developments
13.19 Jingjie PTM BioLab
13.19.1 Jingjie PTM BioLab Company Information
13.19.2 Jingjie PTM BioLab CD115 Antibody Product Portfolios and Specifications
13.19.3 Jingjie PTM BioLab CD115 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Jingjie PTM BioLab Main Business Overview
13.19.5 Jingjie PTM BioLab Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CD115 Antibody Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. CD115 Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal
Table 4. Major Players of Polyclonal
Table 5. Global CD115 Antibody Sales by Type (2021-2026) & (ml)
Table 6. Global CD115 Antibody Sales Market Share by Type (2021-2026)
Table 7. Global CD115 Antibody Revenue by Type (2021-2026) & ($ million)
Table 8. Global CD115 Antibody Revenue Market Share by Type (2021-2026)
Table 9. Global CD115 Antibody Sale Price by Type (2021-2026) & (US$/ml)
Table 10. Global CD115 Antibody Sale by Application (2021-2026) & (ml)
Table 11. Global CD115 Antibody Sale Market Share by Application (2021-2026)
Table 12. Global CD115 Antibody Revenue by Application (2021-2026) & ($ million)
Table 13. Global CD115 Antibody Revenue Market Share by Application (2021-2026)
Table 14. Global CD115 Antibody Sale Price by Application (2021-2026) & (US$/ml)
Table 15. Global CD115 Antibody Sales by Company (2021-2026) & (ml)
Table 16. Global CD115 Antibody Sales Market Share by Company (2021-2026)
Table 17. Global CD115 Antibody Revenue by Company (2021-2026) & ($ millions)
Table 18. Global CD115 Antibody Revenue Market Share by Company (2021-2026)
Table 19. Global CD115 Antibody Sale Price by Company (2021-2026) & (US$/ml)
Table 20. Key Manufacturers CD115 Antibody Producing Area Distribution and Sales Area
Table 21. Players CD115 Antibody Products Offered
Table 22. CD115 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global CD115 Antibody Sales by Geographic Region (2021-2026) & (ml)
Table 26. Global CD115 Antibody Sales Market Share Geographic Region (2021-2026)
Table 27. Global CD115 Antibody Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global CD115 Antibody Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global CD115 Antibody Sales by Country/Region (2021-2026) & (ml)
Table 30. Global CD115 Antibody Sales Market Share by Country/Region (2021-2026)
Table 31. Global CD115 Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global CD115 Antibody Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas CD115 Antibody Sales by Country (2021-2026) & (ml)
Table 34. Americas CD115 Antibody Sales Market Share by Country (2021-2026)
Table 35. Americas CD115 Antibody Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas CD115 Antibody Sales by Type (2021-2026) & (ml)
Table 37. Americas CD115 Antibody Sales by Application (2021-2026) & (ml)
Table 38. APAC CD115 Antibody Sales by Region (2021-2026) & (ml)
Table 39. APAC CD115 Antibody Sales Market Share by Region (2021-2026)
Table 40. APAC CD115 Antibody Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC CD115 Antibody Sales by Type (2021-2026) & (ml)
Table 42. APAC CD115 Antibody Sales by Application (2021-2026) & (ml)
Table 43. Europe CD115 Antibody Sales by Country (2021-2026) & (ml)
Table 44. Europe CD115 Antibody Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe CD115 Antibody Sales by Type (2021-2026) & (ml)
Table 46. Europe CD115 Antibody Sales by Application (2021-2026) & (ml)
Table 47. Middle East & Africa CD115 Antibody Sales by Country (2021-2026) & (ml)
Table 48. Middle East & Africa CD115 Antibody Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa CD115 Antibody Sales by Type (2021-2026) & (ml)
Table 50. Middle East & Africa CD115 Antibody Sales by Application (2021-2026) & (ml)
Table 51. Key Market Drivers & Growth Opportunities of CD115 Antibody
Table 52. Key Market Challenges & Risks of CD115 Antibody
Table 53. Key Industry Trends of CD115 Antibody
Table 54. CD115 Antibody Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. CD115 Antibody Distributors List
Table 57. CD115 Antibody Customer List
Table 58. Global CD115 Antibody Sales Forecast by Region (2027-2032) & (ml)
Table 59. Global CD115 Antibody Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas CD115 Antibody Sales Forecast by Country (2027-2032) & (ml)
Table 61. Americas CD115 Antibody Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC CD115 Antibody Sales Forecast by Region (2027-2032) & (ml)
Table 63. APAC CD115 Antibody Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe CD115 Antibody Sales Forecast by Country (2027-2032) & (ml)
Table 65. Europe CD115 Antibody Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa CD115 Antibody Sales Forecast by Country (2027-2032) & (ml)
Table 67. Middle East & Africa CD115 Antibody Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global CD115 Antibody Sales Forecast by Type (2027-2032) & (ml)
Table 69. Global CD115 Antibody Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global CD115 Antibody Sales Forecast by Application (2027-2032) & (ml)
Table 71. Global CD115 Antibody Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Thermo Fisher Scientific Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 73. Thermo Fisher Scientific CD115 Antibody Product Portfolios and Specifications
Table 74. Thermo Fisher Scientific CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 75. Thermo Fisher Scientific Main Business
Table 76. Thermo Fisher Scientific Latest Developments
Table 77. BosterBio Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 78. BosterBio CD115 Antibody Product Portfolios and Specifications
Table 79. BosterBio CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 80. BosterBio Main Business
Table 81. BosterBio Latest Developments
Table 82. Bioss Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 83. Bioss CD115 Antibody Product Portfolios and Specifications
Table 84. Bioss CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 85. Bioss Main Business
Table 86. Bioss Latest Developments
Table 87. BD Biosciences Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 88. BD Biosciences CD115 Antibody Product Portfolios and Specifications
Table 89. BD Biosciences CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 90. BD Biosciences Main Business
Table 91. BD Biosciences Latest Developments
Table 92. RayBiotech Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 93. RayBiotech CD115 Antibody Product Portfolios and Specifications
Table 94. RayBiotech CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 95. RayBiotech Main Business
Table 96. RayBiotech Latest Developments
Table 97. BioLegend Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 98. BioLegend CD115 Antibody Product Portfolios and Specifications
Table 99. BioLegend CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 100. BioLegend Main Business
Table 101. BioLegend Latest Developments
Table 102. LifeSpan BioSciences Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 103. LifeSpan BioSciences CD115 Antibody Product Portfolios and Specifications
Table 104. LifeSpan BioSciences CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 105. LifeSpan BioSciences Main Business
Table 106. LifeSpan BioSciences Latest Developments
Table 107. Bio-Rad Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 108. Bio-Rad CD115 Antibody Product Portfolios and Specifications
Table 109. Bio-Rad CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 110. Bio-Rad Main Business
Table 111. Bio-Rad Latest Developments
Table 112. Antigenix America Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 113. Antigenix America CD115 Antibody Product Portfolios and Specifications
Table 114. Antigenix America CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 115. Antigenix America Main Business
Table 116. Antigenix America Latest Developments
Table 117. Leinco Technologies Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 118. Leinco Technologies CD115 Antibody Product Portfolios and Specifications
Table 119. Leinco Technologies CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 120. Leinco Technologies Main Business
Table 121. Leinco Technologies Latest Developments
Table 122. Novus Biologicals Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 123. Novus Biologicals CD115 Antibody Product Portfolios and Specifications
Table 124. Novus Biologicals CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 125. Novus Biologicals Main Business
Table 126. Novus Biologicals Latest Developments
Table 127. Tonbo Biosciences Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 128. Tonbo Biosciences CD115 Antibody Product Portfolios and Specifications
Table 129. Tonbo Biosciences CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 130. Tonbo Biosciences Main Business
Table 131. Tonbo Biosciences Latest Developments
Table 132. ichorbio Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 133. ichorbio CD115 Antibody Product Portfolios and Specifications
Table 134. ichorbio CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 135. ichorbio Main Business
Table 136. ichorbio Latest Developments
Table 137. R&D Systems Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 138. R&D Systems CD115 Antibody Product Portfolios and Specifications
Table 139. R&D Systems CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 140. R&D Systems Main Business
Table 141. R&D Systems Latest Developments
Table 142. AffinityImmuno Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 143. AffinityImmuno CD115 Antibody Product Portfolios and Specifications
Table 144. AffinityImmuno CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 145. AffinityImmuno Main Business
Table 146. AffinityImmuno Latest Developments
Table 147. Proteintech Group Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 148. Proteintech Group CD115 Antibody Product Portfolios and Specifications
Table 149. Proteintech Group CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 150. Proteintech Group Main Business
Table 151. Proteintech Group Latest Developments
Table 152. GeneTex Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 153. GeneTex CD115 Antibody Product Portfolios and Specifications
Table 154. GeneTex CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 155. GeneTex Main Business
Table 156. GeneTex Latest Developments
Table 157. Biobyt Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 158. Biobyt CD115 Antibody Product Portfolios and Specifications
Table 159. Biobyt CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 160. Biobyt Main Business
Table 161. Biobyt Latest Developments
Table 162. Jingjie PTM BioLab Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 163. Jingjie PTM BioLab CD115 Antibody Product Portfolios and Specifications
Table 164. Jingjie PTM BioLab CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 165. Jingjie PTM BioLab Main Business
Table 166. Jingjie PTM BioLab Latest Developments
Table 1. CD115 Antibody Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. CD115 Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal
Table 4. Major Players of Polyclonal
Table 5. Global CD115 Antibody Sales by Type (2021-2026) & (ml)
Table 6. Global CD115 Antibody Sales Market Share by Type (2021-2026)
Table 7. Global CD115 Antibody Revenue by Type (2021-2026) & ($ million)
Table 8. Global CD115 Antibody Revenue Market Share by Type (2021-2026)
Table 9. Global CD115 Antibody Sale Price by Type (2021-2026) & (US$/ml)
Table 10. Global CD115 Antibody Sale by Application (2021-2026) & (ml)
Table 11. Global CD115 Antibody Sale Market Share by Application (2021-2026)
Table 12. Global CD115 Antibody Revenue by Application (2021-2026) & ($ million)
Table 13. Global CD115 Antibody Revenue Market Share by Application (2021-2026)
Table 14. Global CD115 Antibody Sale Price by Application (2021-2026) & (US$/ml)
Table 15. Global CD115 Antibody Sales by Company (2021-2026) & (ml)
Table 16. Global CD115 Antibody Sales Market Share by Company (2021-2026)
Table 17. Global CD115 Antibody Revenue by Company (2021-2026) & ($ millions)
Table 18. Global CD115 Antibody Revenue Market Share by Company (2021-2026)
Table 19. Global CD115 Antibody Sale Price by Company (2021-2026) & (US$/ml)
Table 20. Key Manufacturers CD115 Antibody Producing Area Distribution and Sales Area
Table 21. Players CD115 Antibody Products Offered
Table 22. CD115 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global CD115 Antibody Sales by Geographic Region (2021-2026) & (ml)
Table 26. Global CD115 Antibody Sales Market Share Geographic Region (2021-2026)
Table 27. Global CD115 Antibody Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global CD115 Antibody Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global CD115 Antibody Sales by Country/Region (2021-2026) & (ml)
Table 30. Global CD115 Antibody Sales Market Share by Country/Region (2021-2026)
Table 31. Global CD115 Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global CD115 Antibody Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas CD115 Antibody Sales by Country (2021-2026) & (ml)
Table 34. Americas CD115 Antibody Sales Market Share by Country (2021-2026)
Table 35. Americas CD115 Antibody Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas CD115 Antibody Sales by Type (2021-2026) & (ml)
Table 37. Americas CD115 Antibody Sales by Application (2021-2026) & (ml)
Table 38. APAC CD115 Antibody Sales by Region (2021-2026) & (ml)
Table 39. APAC CD115 Antibody Sales Market Share by Region (2021-2026)
Table 40. APAC CD115 Antibody Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC CD115 Antibody Sales by Type (2021-2026) & (ml)
Table 42. APAC CD115 Antibody Sales by Application (2021-2026) & (ml)
Table 43. Europe CD115 Antibody Sales by Country (2021-2026) & (ml)
Table 44. Europe CD115 Antibody Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe CD115 Antibody Sales by Type (2021-2026) & (ml)
Table 46. Europe CD115 Antibody Sales by Application (2021-2026) & (ml)
Table 47. Middle East & Africa CD115 Antibody Sales by Country (2021-2026) & (ml)
Table 48. Middle East & Africa CD115 Antibody Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa CD115 Antibody Sales by Type (2021-2026) & (ml)
Table 50. Middle East & Africa CD115 Antibody Sales by Application (2021-2026) & (ml)
Table 51. Key Market Drivers & Growth Opportunities of CD115 Antibody
Table 52. Key Market Challenges & Risks of CD115 Antibody
Table 53. Key Industry Trends of CD115 Antibody
Table 54. CD115 Antibody Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. CD115 Antibody Distributors List
Table 57. CD115 Antibody Customer List
Table 58. Global CD115 Antibody Sales Forecast by Region (2027-2032) & (ml)
Table 59. Global CD115 Antibody Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas CD115 Antibody Sales Forecast by Country (2027-2032) & (ml)
Table 61. Americas CD115 Antibody Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC CD115 Antibody Sales Forecast by Region (2027-2032) & (ml)
Table 63. APAC CD115 Antibody Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe CD115 Antibody Sales Forecast by Country (2027-2032) & (ml)
Table 65. Europe CD115 Antibody Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa CD115 Antibody Sales Forecast by Country (2027-2032) & (ml)
Table 67. Middle East & Africa CD115 Antibody Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global CD115 Antibody Sales Forecast by Type (2027-2032) & (ml)
Table 69. Global CD115 Antibody Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global CD115 Antibody Sales Forecast by Application (2027-2032) & (ml)
Table 71. Global CD115 Antibody Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Thermo Fisher Scientific Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 73. Thermo Fisher Scientific CD115 Antibody Product Portfolios and Specifications
Table 74. Thermo Fisher Scientific CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 75. Thermo Fisher Scientific Main Business
Table 76. Thermo Fisher Scientific Latest Developments
Table 77. BosterBio Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 78. BosterBio CD115 Antibody Product Portfolios and Specifications
Table 79. BosterBio CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 80. BosterBio Main Business
Table 81. BosterBio Latest Developments
Table 82. Bioss Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 83. Bioss CD115 Antibody Product Portfolios and Specifications
Table 84. Bioss CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 85. Bioss Main Business
Table 86. Bioss Latest Developments
Table 87. BD Biosciences Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 88. BD Biosciences CD115 Antibody Product Portfolios and Specifications
Table 89. BD Biosciences CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 90. BD Biosciences Main Business
Table 91. BD Biosciences Latest Developments
Table 92. RayBiotech Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 93. RayBiotech CD115 Antibody Product Portfolios and Specifications
Table 94. RayBiotech CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 95. RayBiotech Main Business
Table 96. RayBiotech Latest Developments
Table 97. BioLegend Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 98. BioLegend CD115 Antibody Product Portfolios and Specifications
Table 99. BioLegend CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 100. BioLegend Main Business
Table 101. BioLegend Latest Developments
Table 102. LifeSpan BioSciences Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 103. LifeSpan BioSciences CD115 Antibody Product Portfolios and Specifications
Table 104. LifeSpan BioSciences CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 105. LifeSpan BioSciences Main Business
Table 106. LifeSpan BioSciences Latest Developments
Table 107. Bio-Rad Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 108. Bio-Rad CD115 Antibody Product Portfolios and Specifications
Table 109. Bio-Rad CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 110. Bio-Rad Main Business
Table 111. Bio-Rad Latest Developments
Table 112. Antigenix America Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 113. Antigenix America CD115 Antibody Product Portfolios and Specifications
Table 114. Antigenix America CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 115. Antigenix America Main Business
Table 116. Antigenix America Latest Developments
Table 117. Leinco Technologies Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 118. Leinco Technologies CD115 Antibody Product Portfolios and Specifications
Table 119. Leinco Technologies CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 120. Leinco Technologies Main Business
Table 121. Leinco Technologies Latest Developments
Table 122. Novus Biologicals Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 123. Novus Biologicals CD115 Antibody Product Portfolios and Specifications
Table 124. Novus Biologicals CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 125. Novus Biologicals Main Business
Table 126. Novus Biologicals Latest Developments
Table 127. Tonbo Biosciences Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 128. Tonbo Biosciences CD115 Antibody Product Portfolios and Specifications
Table 129. Tonbo Biosciences CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 130. Tonbo Biosciences Main Business
Table 131. Tonbo Biosciences Latest Developments
Table 132. ichorbio Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 133. ichorbio CD115 Antibody Product Portfolios and Specifications
Table 134. ichorbio CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 135. ichorbio Main Business
Table 136. ichorbio Latest Developments
Table 137. R&D Systems Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 138. R&D Systems CD115 Antibody Product Portfolios and Specifications
Table 139. R&D Systems CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 140. R&D Systems Main Business
Table 141. R&D Systems Latest Developments
Table 142. AffinityImmuno Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 143. AffinityImmuno CD115 Antibody Product Portfolios and Specifications
Table 144. AffinityImmuno CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 145. AffinityImmuno Main Business
Table 146. AffinityImmuno Latest Developments
Table 147. Proteintech Group Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 148. Proteintech Group CD115 Antibody Product Portfolios and Specifications
Table 149. Proteintech Group CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 150. Proteintech Group Main Business
Table 151. Proteintech Group Latest Developments
Table 152. GeneTex Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 153. GeneTex CD115 Antibody Product Portfolios and Specifications
Table 154. GeneTex CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 155. GeneTex Main Business
Table 156. GeneTex Latest Developments
Table 157. Biobyt Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 158. Biobyt CD115 Antibody Product Portfolios and Specifications
Table 159. Biobyt CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 160. Biobyt Main Business
Table 161. Biobyt Latest Developments
Table 162. Jingjie PTM BioLab Basic Information, CD115 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 163. Jingjie PTM BioLab CD115 Antibody Product Portfolios and Specifications
Table 164. Jingjie PTM BioLab CD115 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 165. Jingjie PTM BioLab Main Business
Table 166. Jingjie PTM BioLab Latest Developments
LIST OF FIGURES
Figure 1. Picture of CD115 Antibody
Figure 2. CD115 Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CD115 Antibody Sales Growth Rate 2021-2032 (ml)
Figure 7. Global CD115 Antibody Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. CD115 Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. CD115 Antibody Sales Market Share by Country/Region (2025)
Figure 10. CD115 Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monoclonal
Figure 12. Product Picture of Polyclonal
Figure 13. Global CD115 Antibody Sales Market Share by Type in 2026
Figure 14. Global CD115 Antibody Revenue Market Share by Type (2021-2026)
Figure 15. CD115 Antibody Consumed in Immunochemistry (IHC)
Figure 16. Global CD115 Antibody Market: Immunochemistry (IHC) (2021-2026) & (ml)
Figure 17. CD115 Antibody Consumed in Immunofluorescence (IF)
Figure 18. Global CD115 Antibody Market: Immunofluorescence (IF) (2021-2026) & (ml)
Figure 19. CD115 Antibody Consumed in Immunoprecipitation (IP)
Figure 20. Global CD115 Antibody Market: Immunoprecipitation (IP) (2021-2026) & (ml)
Figure 21. CD115 Antibody Consumed in Western Blot (WB)
Figure 22. Global CD115 Antibody Market: Western Blot (WB) (2021-2026) & (ml)
Figure 23. CD115 Antibody Consumed in ELISA
Figure 24. Global CD115 Antibody Market: ELISA (2021-2026) & (ml)
Figure 25. CD115 Antibody Consumed in Others
Figure 26. Global CD115 Antibody Market: Others (2021-2026) & (ml)
Figure 27. Global CD115 Antibody Sale Market Share by Application (2025)
Figure 28. Global CD115 Antibody Revenue Market Share by Application in 2026
Figure 29. CD115 Antibody Sales by Company in 2026 (ml)
Figure 30. Global CD115 Antibody Sales Market Share by Company in 2026
Figure 31. CD115 Antibody Revenue by Company in 2026 ($ millions)
Figure 32. Global CD115 Antibody Revenue Market Share by Company in 2026
Figure 33. Global CD115 Antibody Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global CD115 Antibody Revenue Market Share by Geographic Region in 2026
Figure 35. Americas CD115 Antibody Sales 2021-2026 (ml)
Figure 36. Americas CD115 Antibody Revenue 2021-2026 ($ millions)
Figure 37. APAC CD115 Antibody Sales 2021-2026 (ml)
Figure 38. APAC CD115 Antibody Revenue 2021-2026 ($ millions)
Figure 39. Europe CD115 Antibody Sales 2021-2026 (ml)
Figure 40. Europe CD115 Antibody Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa CD115 Antibody Sales 2021-2026 (ml)
Figure 42. Middle East & Africa CD115 Antibody Revenue 2021-2026 ($ millions)
Figure 43. Americas CD115 Antibody Sales Market Share by Country in 2026
Figure 44. Americas CD115 Antibody Revenue Market Share by Country (2021-2026)
Figure 45. Americas CD115 Antibody Sales Market Share by Type (2021-2026)
Figure 46. Americas CD115 Antibody Sales Market Share by Application (2021-2026)
Figure 47. United States CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC CD115 Antibody Sales Market Share by Region in 2026
Figure 52. APAC CD115 Antibody Revenue Market Share by Region (2021-2026)
Figure 53. APAC CD115 Antibody Sales Market Share by Type (2021-2026)
Figure 54. APAC CD115 Antibody Sales Market Share by Application (2021-2026)
Figure 55. China CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 59. India CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe CD115 Antibody Sales Market Share by Country in 2026
Figure 63. Europe CD115 Antibody Revenue Market Share by Country (2021-2026)
Figure 64. Europe CD115 Antibody Sales Market Share by Type (2021-2026)
Figure 65. Europe CD115 Antibody Sales Market Share by Application (2021-2026)
Figure 66. Germany CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 67. France CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 68. UK CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa CD115 Antibody Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa CD115 Antibody Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa CD115 Antibody Sales Market Share by Application (2021-2026)
Figure 74. Egypt CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of CD115 Antibody in 2026
Figure 80. Manufacturing Process Analysis of CD115 Antibody
Figure 81. Industry Chain Structure of CD115 Antibody
Figure 82. Channels of Distribution
Figure 83. Global CD115 Antibody Sales Market Forecast by Region (2027-2032)
Figure 84. Global CD115 Antibody Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global CD115 Antibody Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global CD115 Antibody Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global CD115 Antibody Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global CD115 Antibody Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of CD115 Antibody
Figure 2. CD115 Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CD115 Antibody Sales Growth Rate 2021-2032 (ml)
Figure 7. Global CD115 Antibody Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. CD115 Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. CD115 Antibody Sales Market Share by Country/Region (2025)
Figure 10. CD115 Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monoclonal
Figure 12. Product Picture of Polyclonal
Figure 13. Global CD115 Antibody Sales Market Share by Type in 2026
Figure 14. Global CD115 Antibody Revenue Market Share by Type (2021-2026)
Figure 15. CD115 Antibody Consumed in Immunochemistry (IHC)
Figure 16. Global CD115 Antibody Market: Immunochemistry (IHC) (2021-2026) & (ml)
Figure 17. CD115 Antibody Consumed in Immunofluorescence (IF)
Figure 18. Global CD115 Antibody Market: Immunofluorescence (IF) (2021-2026) & (ml)
Figure 19. CD115 Antibody Consumed in Immunoprecipitation (IP)
Figure 20. Global CD115 Antibody Market: Immunoprecipitation (IP) (2021-2026) & (ml)
Figure 21. CD115 Antibody Consumed in Western Blot (WB)
Figure 22. Global CD115 Antibody Market: Western Blot (WB) (2021-2026) & (ml)
Figure 23. CD115 Antibody Consumed in ELISA
Figure 24. Global CD115 Antibody Market: ELISA (2021-2026) & (ml)
Figure 25. CD115 Antibody Consumed in Others
Figure 26. Global CD115 Antibody Market: Others (2021-2026) & (ml)
Figure 27. Global CD115 Antibody Sale Market Share by Application (2025)
Figure 28. Global CD115 Antibody Revenue Market Share by Application in 2026
Figure 29. CD115 Antibody Sales by Company in 2026 (ml)
Figure 30. Global CD115 Antibody Sales Market Share by Company in 2026
Figure 31. CD115 Antibody Revenue by Company in 2026 ($ millions)
Figure 32. Global CD115 Antibody Revenue Market Share by Company in 2026
Figure 33. Global CD115 Antibody Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global CD115 Antibody Revenue Market Share by Geographic Region in 2026
Figure 35. Americas CD115 Antibody Sales 2021-2026 (ml)
Figure 36. Americas CD115 Antibody Revenue 2021-2026 ($ millions)
Figure 37. APAC CD115 Antibody Sales 2021-2026 (ml)
Figure 38. APAC CD115 Antibody Revenue 2021-2026 ($ millions)
Figure 39. Europe CD115 Antibody Sales 2021-2026 (ml)
Figure 40. Europe CD115 Antibody Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa CD115 Antibody Sales 2021-2026 (ml)
Figure 42. Middle East & Africa CD115 Antibody Revenue 2021-2026 ($ millions)
Figure 43. Americas CD115 Antibody Sales Market Share by Country in 2026
Figure 44. Americas CD115 Antibody Revenue Market Share by Country (2021-2026)
Figure 45. Americas CD115 Antibody Sales Market Share by Type (2021-2026)
Figure 46. Americas CD115 Antibody Sales Market Share by Application (2021-2026)
Figure 47. United States CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC CD115 Antibody Sales Market Share by Region in 2026
Figure 52. APAC CD115 Antibody Revenue Market Share by Region (2021-2026)
Figure 53. APAC CD115 Antibody Sales Market Share by Type (2021-2026)
Figure 54. APAC CD115 Antibody Sales Market Share by Application (2021-2026)
Figure 55. China CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 59. India CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe CD115 Antibody Sales Market Share by Country in 2026
Figure 63. Europe CD115 Antibody Revenue Market Share by Country (2021-2026)
Figure 64. Europe CD115 Antibody Sales Market Share by Type (2021-2026)
Figure 65. Europe CD115 Antibody Sales Market Share by Application (2021-2026)
Figure 66. Germany CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 67. France CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 68. UK CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa CD115 Antibody Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa CD115 Antibody Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa CD115 Antibody Sales Market Share by Application (2021-2026)
Figure 74. Egypt CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries CD115 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of CD115 Antibody in 2026
Figure 80. Manufacturing Process Analysis of CD115 Antibody
Figure 81. Industry Chain Structure of CD115 Antibody
Figure 82. Channels of Distribution
Figure 83. Global CD115 Antibody Sales Market Forecast by Region (2027-2032)
Figure 84. Global CD115 Antibody Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global CD115 Antibody Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global CD115 Antibody Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global CD115 Antibody Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global CD115 Antibody Revenue Market Share Forecast by Application (2027-2032)
